v3.26.1
Net Loss Per Class A Common Share Attributable to Maravai LifeSciences Holdings, Inc. (Tables)
 6 Months Ended
Jun. 30, 2026
Earnings Per Share [Abstract]  
Summary of Basic and Diluted Net Loss Per Share
The following table presents the computation of basic and diluted net loss per Class A common share attributable to the Company for the periods presented (in thousands, except per share amounts):
Three Months Ended
June 30,		Six Months Ended
June 30,
2026202520262025
Net loss$(21,631)$(69,837)$(28,008)$(122,690)
Less: loss attributable to common non-controlling interests
9,215 30,246 11,859 53,154 
Net loss attributable to Maravai LifeSciences Holdings, Inc.
$(12,416)$(39,591)$(16,149)$(69,536)
Weighted average Class A common shares outstanding
147,996 144,236 147,215 143,833 
Net loss per Class A common share attributable to Maravai LifeSciences Holdings, Inc., basic and diluted$(0.08)$(0.27)$(0.11)$(0.48)
Summary of Dilutive Securities Excluded from Computation of Loss Per Share
The following table presents potentially dilutive securities excluded from the computation of diluted net loss per share for the periods presented because their effect would have been anti-dilutive for the periods presented (in thousands):
Three Months Ended
June 30,		Six Months Ended
June 30,
2026202520262025
Restricted stock units
13,20713,36013,2073,566
Performance-based incentive units7,886—7,886—
Stock options3,4594,5503,4594,550
Shares estimated to be purchased under the employee stock purchase plan
1,0762,0251,0062,025
Shares of Class B common stock110,684110,684110,684110,684
Total136,312130,619136,242120,825